Chemical and Pharmaceutical Bulletin p. 103 - 114 (1996)
Update date:2022-08-02
Topics:
Matsumoto, Yuzo
Tsuzuki, Ryuji
Matsuhisa, Akira
Takayama, Kazuhisa
Yoden, Toru
Uchida, Wataru
Asano, Masaharu
Fujita, Shigeo
Yanagisawa, Isao
Fujikura, Takashi
Strong potassium channel-activating effects were found among a series of novel 4-substituted 3,4-dihydro-2H-1,4-benzoxazine derivatives. The key step in preparation was the nucleophilic substitution of 3,4-dihydro-2H-1,4- benzoxazine (3) with activated halogenopyridines, such as halogenopyridine N- oxides (15a-c) and the borane adduct (15d) of 4-bromopyridine. Structure- activity relationship studies identified 2-(3,4-dihydro-2,2-dimethyl-6- nitro-2H-1,4-benzoxazin-4-yl)pyridine-1-oxide (16a: YM934) as the optimal compound. This compound (16a) showed a more potent oral antihypertensive effect than cromakalim in conscious spontaneously hypertensive rats.
View MoreSHANGHAI ARCADIA BIOTECHNOLOGY LTD.
Contact:+86-21-61353236
Address:SUITE 901, BUILDING WENSLI, 1378 LU JIA BANG RD, SHANGAHI 200011, P.R.CHINA
Shanghai SMEC Trading Co., Ltd.
website:http://www.shanghaismec.com
Contact:+86-21-68811293
Address:ROOM 1101,NO.800 SHANGCHENG RD,SHANGHAI,CHINA
Changzhou Screw International Trading Co., Ltd.
Contact:13906149256,18001495888
Address:Jiangsu，Jintanqu
Contact:+31-24-3886056
Address:Binderskampweg 29 Unit 36
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Doi:10.1021/ja01538a043
(1958)Doi:10.1016/j.bmc.2008.02.019
(2008)Doi:10.1081/SCC-120006014
(2002)Doi:10.1039/b915439f
(2009)Doi:10.1002/ardp.19863190402
(1986)Doi:10.1248/cpb.42.521
(1994)
